To assess tumor proliferation relative to CDK5 expression, we performed immunohistochemical analysis for Ki-67, which identifies proliferating cells, on the tumor xenografts, but we could not measure any significant difference (data not showed). The gene discussed is CDK5; the disease is neoplasm.